BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Prévôt D, Voeltzel T, Birot A, Morel A, Rostan M, Magaud J, Corbo L. The Leukemia-associated Protein Btg1 and the p53-regulated Protein Btg2 Interact with the Homeoprotein Hoxb9 and Enhance Its Transcriptional Activation. Journal of Biological Chemistry 2000;275:147-53. [DOI: 10.1074/jbc.275.1.147] [Cited by in Crossref: 101] [Cited by in F6Publishing: 102] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Zheng HC, Li J, Shen DF, Yang XF, Zhao S, Wu YZ, Takano Y, Sun HZ, Su RJ, Luo JS, Gou WF. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy. Oncotarget 2015;6:19685-705. [PMID: 26050197 DOI: 10.18632/oncotarget.4081] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
2 Waanders E, Scheijen B, van der Meer LT, van Reijmersdal SV, van Emst L, Kroeze Y, Sonneveld E, Hoogerbrugge PM, van Kessel AG, van Leeuwen FN, Kuiper RP. The origin and nature of tightly clustered BTG1 deletions in precursor B-cell acute lymphoblastic leukemia support a model of multiclonal evolution. PLoS Genet 2012;8:e1002533. [PMID: 22359517 DOI: 10.1371/journal.pgen.1002533] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 6.8] [Reference Citation Analysis]
3 Xie J, Wang Q, Wang Q, Yao H, Wen L, Ma L, Wu D, Chen S. High frequency of BTG1 deletions in patients with BCR-ABL1-positive acute leukemia. Cancer Genet 2014;207:226-30. [PMID: 24998463 DOI: 10.1016/j.cancergen.2014.05.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
4 Merabet S, Sambrani N, Pradel J, Graba Y. Regulation of Hox activity: insights from protein motifs. Adv Exp Med Biol 2010;689:3-16. [PMID: 20795319 DOI: 10.1007/978-1-4419-6673-5_1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
5 Deng J, Guo Y, Yuan F, Chen S, Yin H, Jiang X, Jiao F, Wang F, Ji H, Hu G, Ying H, Chen Y, Zhai Q, Xiao F, Guo F. Autophagy inhibition prevents glucocorticoid-increased adiposity via suppressing BAT whitening. Autophagy 2020;16:451-65. [PMID: 31184563 DOI: 10.1080/15548627.2019.1628537] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
6 Park S, Lee YJ, Lee HJ, Seki T, Hong KH, Park J, Beppu H, Lim IK, Yoon JW, Li E, Kim SJ, Oh SP. B-cell translocation gene 2 (Btg2) regulates vertebral patterning by modulating bone morphogenetic protein/smad signaling. Mol Cell Biol 2004;24:10256-62. [PMID: 15542835 DOI: 10.1128/MCB.24.23.10256-10262.2004] [Cited by in Crossref: 50] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
7 Prévôt D, Morel A, Voeltzel T, Rostan M, Rimokh R, Magaud J, Corbo L. Relationships of the Antiproliferative Proteins BTG1 and BTG2 with CAF1, the Human Homolog of a Component of the Yeast CCR4 Transcriptional Complex. Journal of Biological Chemistry 2001;276:9640-8. [DOI: 10.1074/jbc.m008201200] [Cited by in Crossref: 90] [Cited by in F6Publishing: 45] [Article Influence: 4.5] [Reference Citation Analysis]
8 Lipchina I, Elkabetz Y, Hafner M, Sheridan R, Mihailovic A, Tuschl T, Sander C, Studer L, Betel D. Genome-wide identification of microRNA targets in human ES cells reveals a role for miR-302 in modulating BMP response. Genes Dev 2011;25:2173-86. [PMID: 22012620 DOI: 10.1101/gad.17221311] [Cited by in Crossref: 132] [Cited by in F6Publishing: 123] [Article Influence: 13.2] [Reference Citation Analysis]
9 Hata K, Nishijima K, Mizuguchi J. Role for Btg1 and Btg2 in growth arrest of WEHI-231 cells through arginine methylation following membrane immunoglobulin engagement. Exp Cell Res 2007;313:2356-66. [PMID: 17466295 DOI: 10.1016/j.yexcr.2007.03.021] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
10 Yuniati L, van der Meer LT, Tijchon E, van Ingen Schenau D, van Emst L, Levers M, Palit SA, Rodenbach C, Poelmans G, Hoogerbrugge PM, Shan J, Kilberg MS, Scheijen B, van Leeuwen FN. Tumor suppressor BTG1 promotes PRMT1-mediated ATF4 function in response to cellular stress. Oncotarget 2016;7:3128-43. [PMID: 26657730 DOI: 10.18632/oncotarget.6519] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
11 Li X, Xu H, Yi J, Dong C, Zhang H, Wang Z, Miao L, Zhou W. miR-365 secreted from M2 Macrophage-derived extracellular vesicles promotes pancreatic ductal adenocarcinoma progression through the BTG2/FAK/AKT axis. J Cell Mol Med 2021;25:4671-83. [PMID: 33811437 DOI: 10.1111/jcmm.16405] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Kusser W, Zimmer K, Fiedler F. Characteristics of the binding of aminoglycoside antibiotics to teichoic acids. A potential model system for interaction of aminoglycosides with polyanions. Eur J Biochem. 1985;151:601-605. [PMID: 2411558 DOI: 10.1002/dvdy.24060] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
13 Zhao S, Chen SR, Yang XF, Shen DF, Takano Y, Su RJ, Zheng HC. BTG1 might be employed as a biomarker for carcinogenesis and a target for gene therapy in colorectal cancers. Oncotarget. 2017;8:7502-7520. [PMID: 27447746 DOI: 10.18632/oncotarget.10649] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
14 Almasmoum HA, Airhihen B, Seedhouse C, Winkler GS. Frequent loss of BTG1 activity and impaired interactions with the Caf1 subunit of the Ccr4-Not deadenylase in non-Hodgkin lymphoma. Leuk Lymphoma 2021;62:281-90. [PMID: 33021411 DOI: 10.1080/10428194.2020.1827243] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Sakaguchi T, Kuroiwa A, Takeda H. Expression of zebrafish btg-b, an anti-proliferative cofactor, during early embryogenesis. Mechanisms of Development 2001;104:113-5. [DOI: 10.1016/s0925-4773(01)00374-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
16 Passeri D, Marcucci A, Rizzo G, Billi M, Panigada M, Leonardi L, Tirone F, Grignani F. Btg2 enhances retinoic acid-induced differentiation by modulating histone H4 methylation and acetylation. Mol Cell Biol 2006;26:5023-32. [PMID: 16782888 DOI: 10.1128/MCB.01360-05] [Cited by in Crossref: 44] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
17 Lim IK. TIS21 (/BTG2/PC3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule. J Cancer Res Clin Oncol 2006;132:417-26. [PMID: 16456675 DOI: 10.1007/s00432-006-0080-1] [Cited by in Crossref: 73] [Cited by in F6Publishing: 66] [Article Influence: 4.9] [Reference Citation Analysis]
18 Li F, Liu J, Park ES, Jo M, Curry TE Jr. The B cell translocation gene (BTG) family in the rat ovary: hormonal induction, regulation, and impact on cell cycle kinetics. Endocrinology 2009;150:3894-902. [PMID: 19359386 DOI: 10.1210/en.2008-1650] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
19 Quy LN, Choi YW, Kim YH, Chwae YJ, Park TJ, Lim IK. TIS21(/BTG2/PC3) inhibits interleukin-6 expression via downregulation of STAT3 pathway. Cell Signal 2013;25:2391-9. [PMID: 23917204 DOI: 10.1016/j.cellsig.2013.07.024] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
20 Park JI, Kim SG, Baek MW, Park TJ, Lim IK, Seo YW, Chun SY. B-cell translocation gene 2: expression in the rat ovary and potential association with adenine nucleotide translocase 2 in mitochondria. Mol Cell Endocrinol 2013;367:31-40. [PMID: 23267836 DOI: 10.1016/j.mce.2012.12.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
21 Olsson L, Castor A, Behrendtz M, Biloglav A, Forestier E, Paulsson K, Johansson B. Deletions of IKZF1 and SPRED1 are associated with poor prognosis in a population-based series of pediatric B-cell precursor acute lymphoblastic leukemia diagnosed between 1992 and 2011. Leukemia 2014;28:302-10. [PMID: 23823658 DOI: 10.1038/leu.2013.206] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 6.3] [Reference Citation Analysis]
22 Zhang N, Jiang T, Wang Y, Wang S, Hu L, Bu Y. BTG4 is A Novel p53 Target Gene That Inhibits Cell Growth and Induces Apoptosis. Genes (Basel) 2020;11:E217. [PMID: 32093041 DOI: 10.3390/genes11020217] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
23 Zhang Z, Chen C, Wang G, Yang Z, San J, Zheng J, Li Q, Luo X, Hu Q, Li Z. Aberrant expression of the p53-inducible antiproliferative gene BTG2 in hepatocellular carcinoma is associated with overexpression of the cell cycle-related proteins. Cell Biochem Biophys. 2011;61:83-91. [PMID: 21327578 DOI: 10.1007/s12013-011-9164-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
24 Ismail HM, Hurd PJ, Khalil MI, Kouzarides T, Bannister A, Gout I. S6 Kinase 2 Is Bound to Chromatin-Nuclear Matrix Cellular Fractions and Is Able to Phosphorylate Histone H3 at Threonine 45 In Vitro and In Vivo: S6K2 Binds to Chromatin and Phosphorylates Histone H3. J Cell Biochem 2014;115:1048-62. [DOI: 10.1002/jcb.24566] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
25 Berthet C, Guéhenneux F, Revol V, Samarut C, Lukaszewicz A, Dehay C, Dumontet C, Magaud JP, Rouault JP. Interaction of PRMT1 with BTG/TOB proteins in cell signalling: molecular analysis and functional aspects. Genes Cells 2002;7:29-39. [PMID: 11856371 DOI: 10.1046/j.1356-9597.2001.00497.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 3.1] [Reference Citation Analysis]
26 Liu R, Cheng Q, Wang X, Chen H, Wang W, Zhang H, Wang L, Song L. The B-cell translocation gene 1 ( Cg BTG1) identified in oyster Crassostrea gigas exhibit multiple functions in immune response. Fish & Shellfish Immunology 2017;61:68-78. [DOI: 10.1016/j.fsi.2016.12.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
27 Hao Y, Wang J, Zhao L. The effect and mechanism of miR196a in HepG2 cell. Biomed Pharmacother 2015;72:1-5. [PMID: 26054667 DOI: 10.1016/j.biopha.2014.10.032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
28 Micheli L, Ceccarelli M, Farioli-vecchioli S, Tirone F. Control of the Normal and Pathological Development of Neural Stem and Progenitor Cells by the PC3/Tis21/Btg2 and Btg1 Genes: BTG GENES AND NEURAL STEM CELL DEVELOPMENT. J Cell Physiol 2015;230:2881-90. [DOI: 10.1002/jcp.25038] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
29 Wessely O, Kim JI, Tran U, Fuentealba L, De Robertis EM. xBtg-x regulates Wnt/beta-Catenin signaling during early Xenopus development. Dev Biol 2005;283:17-28. [PMID: 15975429 DOI: 10.1016/j.ydbio.2005.03.033] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
30 Masumura Y, Higo S, Asano Y, Kato H, Yan Y, Ishino S, Tsukamoto O, Kioka H, Hayashi T, Shintani Y, Yamazaki S, Minamino T, Kitakaze M, Komuro I, Takashima S, Sakata Y. Btg2 is a Negative Regulator of Cardiomyocyte Hypertrophy through a Decrease in Cytosolic RNA. Sci Rep 2016;6:28592. [PMID: 27346836 DOI: 10.1038/srep28592] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
31 Suzuki M, Ueno N, Kuroiwa A. Hox Proteins Functionally Cooperate with the GC Box-binding Protein System through Distinct Domains. Journal of Biological Chemistry 2003;278:30148-56. [DOI: 10.1074/jbc.m303932200] [Cited by in Crossref: 31] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
32 Dragon S, Offenhäuser N, Baumann R. cAMP and in vivo hypoxia induce tob, ifr1, and fos expression in erythroid cells of the chick embryo. Am J Physiol Regul Integr Comp Physiol 2002;282:R1219-26. [PMID: 11893628 DOI: 10.1152/ajpregu.00507.2001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
33 Tijchon E, van Ingen Schenau D, van Opzeeland F, Tirone F, Hoogerbrugge PM, Van Leeuwen FN, Scheijen B. Targeted Deletion of Btg1 and Btg2 Results in Homeotic Transformation of the Axial Skeleton. PLoS One 2015;10:e0131481. [PMID: 26218146 DOI: 10.1371/journal.pone.0131481] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
34 Sugimoto K, Hayata T, Asashima M. XBtg2 is required for notochord differentiation during early Xenopus development. Dev Growth Differ 2005;47:435-43. [PMID: 16179070 DOI: 10.1111/j.1440-169X.2005.00819.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
35 Wu X, Ding N, Hu W, He J, Xu S, Pei H, Hua J, Zhou G, Wang J. Down-regulation of BTG1 by miR-454-3p enhances cellular radiosensitivity in renal carcinoma cells. Radiat Oncol 2014;9:179. [PMID: 25115181 DOI: 10.1186/1748-717X-9-179] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
36 Rodier A, Rochard P, Berthet C, Rouault JP, Casas F, Daury L, Busson M, Magaud JP, Wrutniak-Cabello C, Cabello G. Identification of functional domains involved in BTG1 cell localization. Oncogene 2001;20:2691-703. [PMID: 11420681 DOI: 10.1038/sj.onc.1204398] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
37 Xiao F, Deng J, Guo Y, Niu Y, Yuan F, Yu J, Chen S, Guo F. BTG1 ameliorates liver steatosis by decreasing stearoyl-CoA desaturase 1 (SCD1) abundance and altering hepatic lipid metabolism. Sci Signal 2016;9:ra50. [PMID: 27188441 DOI: 10.1126/scisignal.aad8581] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
38 Yoshida Y, von Bubnoff A, Ikematsu N, Blitz IL, Tsuzuku JK, Yoshida EH, Umemori H, Miyazono K, Yamamoto T, Cho KW. Tob proteins enhance inhibitory Smad-receptor interactions to repress BMP signaling. Mech Dev 2003;120:629-37. [PMID: 12782279 DOI: 10.1016/s0925-4773(03)00020-0] [Cited by in Crossref: 41] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
39 Lindblad O, Chougule RA, Moharram SA, Kabir NN, Sun J, Kazi JU, Rönnstrand L. The role of HOXB2 and HOXB3 in acute myeloid leukemia. Biochem Biophys Res Commun 2015;467:742-7. [PMID: 26482852 DOI: 10.1016/j.bbrc.2015.10.071] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
40 Lee H, Cha S, Lee MS, Cho GJ, Choi WS, Suk K. Role of antiproliferative B cell translocation gene-1 as an apoptotic sensitizer in activation-induced cell death of brain microglia. J Immunol 2003;171:5802-11. [PMID: 14634089 DOI: 10.4049/jimmunol.171.11.5802] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 2.9] [Reference Citation Analysis]
41 Okochi K, Suzuki T, Inoue J, Matsuda S, Yamamoto T. Interaction of anti-proliferative protein Tob with poly(A)-binding protein and inducible poly(A)-binding protein: implication of Tob in translational control: Tob protein in translation machinery. Genes to Cells 2005;10:151-63. [DOI: 10.1111/j.1365-2443.2005.00826.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 3.2] [Reference Citation Analysis]
42 Sasajima H, Nakagawa K, Yokosawa H. Antiproliferative proteins of the BTG/Tob family are degraded by the ubiquitin-proteasome system. Eur J Biochem 2002;269:3596-604. [PMID: 12135500 DOI: 10.1046/j.1432-1033.2002.03052.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 2.1] [Reference Citation Analysis]
43 Mauxion F, Chen CY, Séraphin B, Shyu AB. BTG/TOB factors impact deadenylases. Trends Biochem Sci 2009;34:640-7. [PMID: 19828319 DOI: 10.1016/j.tibs.2009.07.008] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 4.5] [Reference Citation Analysis]
44 Tzachanis D, Boussiotis VA. Tob, a member of the APRO family, regulates immunological quiescence and tumor suppression. Cell Cycle 2009;8:1019-25. [PMID: 19270514 DOI: 10.4161/cc.8.7.8033] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
45 Mauxion F, Faux C, Séraphin B. The BTG2 protein is a general activator of mRNA deadenylation. EMBO J 2008;27:1039-48. [PMID: 18337750 DOI: 10.1038/emboj.2008.43] [Cited by in Crossref: 77] [Cited by in F6Publishing: 73] [Article Influence: 5.9] [Reference Citation Analysis]
46 Karve TM, Rosen EM. B-cell translocation gene 2 (BTG2) stimulates cellular antioxidant defenses through the antioxidant transcription factor NFE2L2 in human mammary epithelial cells. J Biol Chem 2012;287:31503-14. [PMID: 22493435 DOI: 10.1074/jbc.M112.367433] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
47 Hong JW, Ryu MS, Lim IK. Phosphorylation of Serine 147 of tis21/BTG2/pc3 by p-Erk1/2 Induces Pin-1 Binding in Cytoplasm and Cell Death. Journal of Biological Chemistry 2005;280:21256-63. [DOI: 10.1074/jbc.m500318200] [Cited by in Crossref: 43] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
48 Yoshida Y, Tanaka S, Umemori H, Minowa O, Usui M, Ikematsu N, Hosoda E, Imamura T, Kuno J, Yamashita T, Miyazono K, Noda M, Noda T, Yamamoto T. Negative regulation of BMP/Smad signaling by Tob in osteoblasts. Cell 2000;103:1085-97. [PMID: 11163184 DOI: 10.1016/s0092-8674(00)00211-7] [Cited by in Crossref: 235] [Cited by in F6Publishing: 84] [Article Influence: 11.8] [Reference Citation Analysis]
49 Kim J, Kim YH, Han JH, Lee KB, Sheen SS, Lee J, Soh E, Park TJ. Silencing of homeobox B9 is associated with down-regulation of CD56 and extrathyroidal extension of tumor in papillary thyroid carcinoma. Human Pathology 2012;43:1221-8. [DOI: 10.1016/j.humpath.2011.09.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
50 Abramovich C, Humphries RK. Hox regulation of normal and leukemic hematopoietic stem cells: . Current Opinion in Hematology 2005;12:210-6. [DOI: 10.1097/01.moh.0000160737.52349.aa] [Cited by in Crossref: 109] [Cited by in F6Publishing: 98] [Article Influence: 6.8] [Reference Citation Analysis]
51 Nakamura T, Yao R, Ogawa T, Suzuki T, Ito C, Tsunekawa N, Inoue K, Ajima R, Miyasaka T, Yoshida Y, Ogura A, Toshimori K, Noce T, Yamamoto T, Noda T. Oligo-astheno-teratozoospermia in mice lacking Cnot7, a regulator of retinoid X receptor beta. Nat Genet 2004;36:528-33. [PMID: 15107851 DOI: 10.1038/ng1344] [Cited by in Crossref: 89] [Cited by in F6Publishing: 82] [Article Influence: 5.2] [Reference Citation Analysis]
52 Micheli L, D'Andrea G, Leonardi L, Tirone F. HDAC1, HDAC4, and HDAC9 Bind to PC3/Tis21/Btg2 and Are Required for Its Inhibition of Cell Cycle Progression and Cyclin D1 Expression. J Cell Physiol 2017;232:1696-707. [PMID: 27333946 DOI: 10.1002/jcp.25467] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
53 Kamaid A, Giráldez F. Btg1 and Btg2 gene expression during early chick development. Dev Dyn 2008;237:2158-69. [PMID: 18651656 DOI: 10.1002/dvdy.21616] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
54 Aslam A, Mittal S, Koch F, Andrau JC, Winkler GS. The Ccr4-NOT deadenylase subunits CNOT7 and CNOT8 have overlapping roles and modulate cell proliferation. Mol Biol Cell 2009;20:3840-50. [PMID: 19605561 DOI: 10.1091/mbc.e09-02-0146] [Cited by in Crossref: 67] [Cited by in F6Publishing: 55] [Article Influence: 5.6] [Reference Citation Analysis]
55 Melamed J, Kernizan S, Walden PD. Expression of B-cell translocation gene 2 protein in normal human tissues. Tissue Cell 2002;34:28-32. [PMID: 11989967 DOI: 10.1054/tice.2001.0220] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 2.0] [Reference Citation Analysis]
56 Morel AP, Sentis S, Bianchin C, Le Romancer M, Jonard L, Rostan MC, Rimokh R, Corbo L. BTG2 antiproliferative protein interacts with the human CCR4 complex existing in vivo in three cell-cycle-regulated forms. J Cell Sci 2003;116:2929-36. [PMID: 12771185 DOI: 10.1242/jcs.00480] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 2.8] [Reference Citation Analysis]
57 Mann RS, Lelli KM, Joshi R. Hox specificity unique roles for cofactors and collaborators. Curr Top Dev Biol 2009;88:63-101. [PMID: 19651302 DOI: 10.1016/S0070-2153(09)88003-4] [Cited by in Crossref: 200] [Cited by in F6Publishing: 149] [Article Influence: 16.7] [Reference Citation Analysis]
58 Yang X, Morita M, Wang H, Suzuki T, Yang W, Luo Y, Zhao C, Yu Y, Bartlam M, Yamamoto T, Rao Z. Crystal structures of human BTG2 and mouse TIS21 involved in suppression of CAF1 deadenylase activity. Nucleic Acids Res 2008;36:6872-81. [PMID: 18974182 DOI: 10.1093/nar/gkn825] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
59 Ajima R, Akiyama T, Usui M, Yoneda M, Yoshida Y, Nakamura T, Minowa O, Noda M, Tanaka S, Noda T, Yamamoto T. Osteoporotic bone formation in mice lacking tob2; involvement of Tob2 in RANK ligand expression and osteoclasts differentiation. FEBS Lett 2008;582:1313-8. [PMID: 18358842 DOI: 10.1016/j.febslet.2008.03.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
60 Yoshida Y, Hosoda E, Nakamura T, Yamamoto T. Association of ANA, a member of the antiproliferative Tob family proteins, with a Caf1 component of the CCR4 transcriptional regulatory complex. Jpn J Cancer Res 2001;92:592-6. [PMID: 11429045 DOI: 10.1111/j.1349-7006.2001.tb01135.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 31] [Article Influence: 1.3] [Reference Citation Analysis]
61 Devanand P, Sundaramoorthy S, Ryu MS, Jayabalan AK, Ohn T, Lim IK. Translational downregulation of Twist1 expression by antiproliferative gene, B-cell translocation gene 2, in the triple negative breast cancer cells. Cell Death Dis 2019;10:410. [PMID: 31138781 DOI: 10.1038/s41419-019-1640-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
62 Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA. 2001;98:5116-5121. [PMID: 11309499 DOI: 10.1073/pnas.091062498] [Cited by in Crossref: 8535] [Cited by in F6Publishing: 7630] [Article Influence: 426.8] [Reference Citation Analysis]
63 Yuniati L, Scheijen B, van der Meer LT, van Leeuwen FN. Tumor suppressors BTG1 and BTG2: Beyond growth control. J Cell Physiol 2019;234:5379-89. [PMID: 30350856 DOI: 10.1002/jcp.27407] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 16.0] [Reference Citation Analysis]
64 Kanda M, Sugimoto H, Kodera Y. Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma. World J Gastroenterol. 2015;21:10584-10597. [PMID: 26457018 DOI: 10.3748/wjg.v21.i37.10584] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 41] [Article Influence: 7.4] [Reference Citation Analysis]
65 Das S, Sarkar D, Das B. The interplay between transcription and mRNA degradation in Saccharomyces cerevisiae. Microb Cell 2017;4:212-28. [PMID: 28706937 DOI: 10.15698/mic2017.07.580] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
66 Stupfler B, Birck C, Séraphin B, Mauxion F. BTG2 bridges PABPC1 RNA-binding domains and CAF1 deadenylase to control cell proliferation. Nat Commun 2016;7:10811. [PMID: 26912148 DOI: 10.1038/ncomms10811] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 8.0] [Reference Citation Analysis]
67 Ceccarelli M, Micheli L, D'andrea G, De Bardi M, Scheijen B, Ciotti M, Leonardi L, Luvisetto S, Tirone F. Altered cerebellum development and impaired motor coordination in mice lacking the Btg1 gene: Involvement of cyclin D1. Developmental Biology 2015;408:109-25. [DOI: 10.1016/j.ydbio.2015.10.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
68 Tirone F. The gene PC3TIS21/BTG2, prototype member of the PC3/BTG/TOB family: Regulator in control of cell growth, differentiation, and DNA repair? J Cell Physiol 2001;187:155-65. [DOI: 10.1002/jcp.1062] [Cited by in Crossref: 166] [Cited by in F6Publishing: 158] [Article Influence: 8.3] [Reference Citation Analysis]
69 van Galen JC, Kuiper RP, van Emst L, Levers M, Tijchon E, Scheijen B, Waanders E, van Reijmersdal SV, Gilissen C, van Kessel AG, Hoogerbrugge PM, van Leeuwen FN. BTG1 regulates glucocorticoid receptor autoinduction in acute lymphoblastic leukemia. Blood 2010;115:4810-9. [PMID: 20354172 DOI: 10.1182/blood-2009-05-223081] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 4.5] [Reference Citation Analysis]
70 Morita M, Ito K, Suzuki T, Yamamoto T. Involvement of the CCR4-NOT Deadenylase Complex in the Control of Cell Growth. In: Nakanishi S, Kageyama R, Watanabe D, editors. Systems Biology. Tokyo: Springer Japan; 2009. pp. 229-37. [DOI: 10.1007/978-4-431-87704-2_24] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
71 Merabet S, Dard A. Tracking context-specific transcription factors regulating hox activity. Dev Dyn 2014;243:16-23. [PMID: 23794379 DOI: 10.1002/dvdy.24002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
72 Calvo R, West J, Franklin W, Erickson P, Bemis L, Li E, Helfrich B, Bunn P, Roche J, Brambilla E, Rosell R, Gemmill RM, Drabkin HA. Altered HOX and WNT7A expression in human lung cancer. Proc Natl Acad Sci U S A 2000;97:12776-81. [PMID: 11070089 DOI: 10.1073/pnas.97.23.12776] [Cited by in Crossref: 148] [Cited by in F6Publishing: 147] [Article Influence: 7.4] [Reference Citation Analysis]
73 Thorns C, Gaiser T, Lange K, Merz H, Feller AC. cDNA arrays: Gene expression profiles of Hodgkin's disease and anaplastic large cell lymphoma cell lines: cDNA arrays for gene expression in lymphoma. Pathology International 2002;52:578-85. [DOI: 10.1046/j.1320-5463.2002.01400.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
74 Matsuda S, Rouault J, Magaud J, Berthet C. In search of a function for the TIS21/PC3/BTG1/TOB family. FEBS Letters 2001;497:67-72. [DOI: 10.1016/s0014-5793(01)02436-x] [Cited by in Crossref: 169] [Cited by in F6Publishing: 77] [Article Influence: 8.5] [Reference Citation Analysis]
75 Maguer-satta V, Forissier S, Bartholin L, Martel S, Jeanpierre S, Bachelard E, Rimokh R. A novel role for fibronectin type I domain in the regulation of human hematopoietic cell adhesiveness through binding to follistatin domains of FLRG and follistatin. Experimental Cell Research 2006;312:434-42. [DOI: 10.1016/j.yexcr.2005.11.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
76 Li E, Han K, Zhou X. microRNA-27a-3p Down-regulation Inhibits Malignant Biological Behaviors of Ovarian Cancer by Targeting BTG1. Open Med (Wars) 2019;14:577-85. [PMID: 31410369 DOI: 10.1515/med-2019-0065] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
77 Hwang SL, Kwon O, Lee SJ, Roh SS, Kim YD, Choi JH. B-cell translocation gene-2 increases hepatic gluconeogenesis via induction of CREB. Biochem Biophys Res Commun 2012;427:801-5. [PMID: 23058912 DOI: 10.1016/j.bbrc.2012.09.146] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
78 Suzuki T, K-Tsuzuku J, Ajima R, Nakamura T, Yoshida Y, Yamamoto T. Phosphorylation of three regulatory serines of Tob by Erk1 and Erk2 is required for Ras-mediated cell proliferation and transformation. Genes Dev 2002;16:1356-70. [PMID: 12050114 DOI: 10.1101/gad.962802] [Cited by in Crossref: 97] [Cited by in F6Publishing: 86] [Article Influence: 5.1] [Reference Citation Analysis]
79 Tzachanis D, Lafuente EM, Li L, Boussiotis VA. Intrinsic and extrinsic regulation of T lymphocyte quiescence. Leuk Lymphoma 2004;45:1959-67. [PMID: 15370239 DOI: 10.1080/1042819042000219494] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
80 Yoshida Y, Nakamura T, Komoda M, Satoh H, Suzuki T, Tsuzuku JK, Miyasaka T, Yoshida EH, Umemori H, Kunisaki RK, Tani K, Ishii S, Mori S, Suganuma M, Noda T, Yamamoto T. Mice lacking a transcriptional corepressor Tob are predisposed to cancer. Genes Dev 2003;17:1201-6. [PMID: 12756225 DOI: 10.1101/gad.1088003] [Cited by in Crossref: 86] [Cited by in F6Publishing: 77] [Article Influence: 4.8] [Reference Citation Analysis]
81 Zhao Y, Gou WF, Chen S, Takano Y, Xiu YL, Zheng HC. BTG1 expression correlates with the pathogenesis and progression of ovarian carcinomas. Int J Mol Sci. 2013;14:19670-19680. [PMID: 24084718 DOI: 10.3390/ijms141019670] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
82 Liu C, Tao T, Xu B, Lu K, Zhang L, Jiang L, Chen S, Liu D, Zhang X, Cao N, Chen M. BTG1 potentiates apoptosis and suppresses proliferation in renal cell carcinoma by interacting with PRMT1. Oncol Lett 2015;10:619-24. [PMID: 26622543 DOI: 10.3892/ol.2015.3293] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
83 Robin-lespinasse Y, Sentis S, Kolytcheff C, Rostan M, Corbo L, Le Romancer M. hCAF1, a new regulator of PRMT1-dependent arginine methylation. Journal of Cell Science 2007;120:638-47. [DOI: 10.1242/jcs.03357] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 3.9] [Reference Citation Analysis]
84 Nagel S, Burek C, Venturini L, Scherr M, Quentmeier H, Meyer C, Rosenwald A, Drexler HG, MacLeod RA. Comprehensive analysis of homeobox genes in Hodgkin lymphoma cell lines identifies dysregulated expression of HOXB9 mediated via ERK5 signaling and BMI1. Blood 2007;109:3015-23. [PMID: 17148583 DOI: 10.1182/blood-2006-08-044347] [Cited by in Crossref: 57] [Cited by in F6Publishing: 49] [Article Influence: 4.1] [Reference Citation Analysis]
85 Chang Q, Zhang L, He C, Zhang B, Zhang J, Liu B, Zeng N, Zhu Z. HOXB9 induction of mesenchymal-to-epithelial transition in gastric carcinoma is negatively regulated by its hexapeptide motif. Oncotarget 2015;6:42838-53. [PMID: 26536658 DOI: 10.18632/oncotarget.5814] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
86 Ceccarelli M, D'Andrea G, Micheli L, Tirone F. Deletion of Btg1 Induces Prmt1-Dependent Apoptosis and Increased Stemness in Shh-Type Medulloblastoma Cells Without Affecting Tumor Frequency. Front Oncol 2020;10:226. [PMID: 32231994 DOI: 10.3389/fonc.2020.00226] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
87 Maguer-Satta V, Bartholin L, Jeanpierre S, Gadoux M, Bertrand S, Martel S, Magaud JP, Rimokh R. Expression of FLRG, a novel activin A ligand, is regulated by TGF-beta and during hematopoiesis [corrected]. Exp Hematol 2001;29:301-8. [PMID: 11274757 DOI: 10.1016/s0301-472x(00)00675-5] [Cited by in Crossref: 35] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
88 Kanda M, Oya H, Nomoto S, Takami H, Shimizu D, Hashimoto R, Sueoka S, Kobayashi D, Tanaka C, Yamada S. Diversity of clinical implication of B-cell translocation gene 1 expression by histopathologic and anatomic subtypes of gastric cancer. Dig Dis Sci. 2015;60:1256-1264. [PMID: 25487193 DOI: 10.1007/s10620-014-3477-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
89 Miyasaka T, Morita M, Ito K, Suzuki T, Fukuda H, Takeda S, Inoue J, Semba K, Yamamoto T. Interaction of antiproliferative protein Tob with the CCR4-NOT deadenylase complex. Cancer Sci 2008;99:755-61. [PMID: 18377426 DOI: 10.1111/j.1349-7006.2008.00746.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
90 Lim SK, Choi YW, Lim IK, Park TJ. BTG2 suppresses cancer cell migration through inhibition of Src-FAK signaling by downregulation of reactive oxygen species generation in mitochondria. Clin Exp Metastasis 2012;29:901-13. [PMID: 22562501 DOI: 10.1007/s10585-012-9479-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
91 Bard MP, Hegmans JP, Hemmes A, Luider TM, Willemsen R, Severijnen LA, van Meerbeeck JP, Burgers SA, Hoogsteden HC, Lambrecht BN. Proteomic analysis of exosomes isolated from human malignant pleural effusions. Am J Respir Cell Mol Biol 2004;31:114-21. [PMID: 14975938 DOI: 10.1165/rcmb.2003-0238OC] [Cited by in Crossref: 275] [Cited by in F6Publishing: 138] [Article Influence: 16.2] [Reference Citation Analysis]
92 Bakker WJ, Blázquez-Domingo M, Kolbus A, Besooyen J, Steinlein P, Beug H, Coffer PJ, Löwenberg B, von Lindern M, van Dijk TB. FoxO3a regulates erythroid differentiation and induces BTG1, an activator of protein arginine methyl transferase 1. J Cell Biol 2004;164:175-84. [PMID: 14734530 DOI: 10.1083/jcb.200307056] [Cited by in Crossref: 119] [Cited by in F6Publishing: 115] [Article Influence: 7.0] [Reference Citation Analysis]
93 Xiao F, Deng J, Yu J, Guo Y, Chen S, Guo F. A novel function of B‐cell translocation gene 1 ( BTG1 ) in the regulation of hepatic insulin sensitivity in mice via c‐Jun. FASEB j 2015;30:348-59. [DOI: 10.1096/fj.15-278689] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
94 Tirone F, Farioli-Vecchioli S, Micheli L, Ceccarelli M, Leonardi L. Genetic control of adult neurogenesis: interplay of differentiation, proliferation and survival modulates new neurons function, and memory circuits. Front Cell Neurosci 2013;7:59. [PMID: 23734097 DOI: 10.3389/fncel.2013.00059] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
95 Hayashida T, Takahashi F, Chiba N, Brachtel E, Takahashi M, Godin-Heymann N, Gross KW, Vivanco Md, Wijendran V, Shioda T, Sgroi D, Donahoe PK, Maheswaran S. HOXB9, a gene overexpressed in breast cancer, promotes tumorigenicity and lung metastasis. Proc Natl Acad Sci U S A 2010;107:1100-5. [PMID: 20080567 DOI: 10.1073/pnas.0912710107] [Cited by in Crossref: 114] [Cited by in F6Publishing: 105] [Article Influence: 9.5] [Reference Citation Analysis]
96 Sugimoto K, Okabayashi K, Sedohara A, Hayata T, Asashima M. The role of XBtg2 in Xenopus neural development. Dev Neurosci 2007;29:468-79. [PMID: 17119321 DOI: 10.1159/000097320] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
97 Takahashi F, Chiba N, Tajima K, Hayashida T, Shimada T, Takahashi M, Moriyama H, Brachtel E, Edelman EJ, Ramaswamy S, Maheswaran S. Breast tumor progression induced by loss of BTG2 expression is inhibited by targeted therapy with the ErbB/HER inhibitor lapatinib. Oncogene 2011;30:3084-95. [PMID: 21339742 DOI: 10.1038/onc.2011.24] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
98 Bartlam M, Yamamoto T. The structural basis for deadenylation by the CCR4-NOT complex. Protein Cell 2010;1:443-52. [PMID: 21203959 DOI: 10.1007/s13238-010-0060-8] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
99 Zhang S, Steijaert MN, Lau D, Schütz G, Delucinge-vivier C, Descombes P, Bading H. Decoding NMDA Receptor Signaling: Identification of Genomic Programs Specifying Neuronal Survival and Death. Neuron 2007;53:549-62. [DOI: 10.1016/j.neuron.2007.01.025] [Cited by in Crossref: 208] [Cited by in F6Publishing: 206] [Article Influence: 14.9] [Reference Citation Analysis]
100 Winkler GS. The mammalian anti-proliferative BTG/Tob protein family. J Cell Physiol 2010;222:66-72. [DOI: 10.1002/jcp.21919] [Cited by in Crossref: 180] [Cited by in F6Publishing: 167] [Article Influence: 16.4] [Reference Citation Analysis]
101 Su C, Huang DP, Liu JW, Liu WY, Cao YO. miR-27a-3p regulates proliferation and apoptosis of colon cancer cells by potentially targeting BTG1. Oncol Lett 2019;18:2825-34. [PMID: 31452761 DOI: 10.3892/ol.2019.10629] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
102 Ghazavi F, Lammens T, Van Roy N, Poppe B, Speleman F, Benoit Y, Van Vlierberghe P, De Moerloose B. Molecular basis and clinical significance of genetic aberrations in B-cell precursor acute lymphoblastic leukemia. Experimental Hematology 2015;43:640-53. [DOI: 10.1016/j.exphem.2015.05.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]